Login / Signup

Residual anti-Xa activity in plasma of patients presenting for electively planned neuraxial regional anesthesia.

Julian KnoerleinPhilipp BrodbeckMartin BüchselBarbara ZiegerAxel Schmutz
Published in: Regional anesthesia and pain medicine (2023)
German Clinical Trials Register DRKS00022099.
Keyphrases
  • clinical trial
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • randomized controlled trial
  • case report
  • study protocol